Carmell Therapeutics
-
Biologics
Carmell Announces Successful Closing of Merger with Axolotl Biologix and Launch of a New Brand Identity
PITTSBURGH & FLAGSTAFF, Ariz., August 9, 2023 /OrthoSpineNews/–Carmell Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative care company today announced the successful…
Read More » -
Biologics
Carmell Therapeutics Announces Merger with Axolotl Biologix, a Profitable Regenerative Medicine Company
PITTSBURGH & FLAGSTAFF, Ariz., July 27, 2023 – OrthoSpineNews – Carmell Therapeutics Corporation (Nasdaq: CTCX) (“Carmell”), a regenerative medicine company…
Read More » -
Financial
Carmell Therapeutics closes $4M Series B round of funding
PITTSBURGH, July 11, 2017 /PRNewswire/ — Carmell Therapeutics, a biotechnology company focused on developing and commercializing regenerative medicine technologies, announced today that on June…
Read More »